Payer PolicyActive
SURG.00124 Carotid Sinus Baroreceptor Stimulation Devices
ANTHEM-SURG.00124
Anthem
Effective: December 18, 2025
Updated: December 30, 2025
Policy Summary
- Policy addresses carotid sinus baroreceptor (baroreflex) stimulation devices and related procedures for hypertension (including drug‑resistant hypertension) and heart failure. - Coverage: Not covered. Anthem deems baroreflex activation devices investigational/experimental and not medically necessary for all indications. - Key limitations: No covered indications or exceptions; services associated with these devices (including implantation and programming) are not covered.
Coverage Criteria Preview
Key requirements from the full policy
"The use of a carotid sinus baroreflex activation device is consideredinvestigational and not medically necessaryfor all indications."
Sign up to see full coverage criteria, indications, and limitations.